Emodin Inhibits Inflammation, Carcinogenesis, and Cancer Progression in the AOM/DSS Model of Colitis-Associated Intestinal Tumorigenesis

Emodin Inhibits Inflammation, Carcinogenesis, and Cancer Progression in the AOM/DSS Model of Colitis-Associated Intestinal Tumorigenesis

Colorectal cancer (CRC) is one of the most common cancer worldwide. Chronic inflammation contributes to CRC development and progression. Emodin, is a natural anthraquinone derivative with anti-oxidant, anti-inflammatory, and anti-tumor activities. We used the AOM/DSS model of colitis-associated inte...

Full description

Bibliographic Details
Main Authors: Yunsha Zhang, Weiling Pu, Mélanie Bousquenaud, Sarah Cattin, Jelena Zaric, Li-kang Sun, Curzio Rüegg
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Oncology
Subjects:
emodin
colorectal cancer
Chinese medicine
tumor microenvironment
inflammation
T lymphocytes
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.564674/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.564674/full

Similar Items